Burtech Acquisition Corp. (BNBX) Stock

Burtech Acquisition Corp. (BNBX) is a stock trading at $10.01 (as of 2026-08-28), with a market capitalization of $83.07M and a trailing P/E of 494.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Understand Burtech Acquisition Corp.: how it makes money

BNB Plus Corp. operates in the business-services side of technology, generating revenue from service contracts. The company is at a very early scale with essentially no measurable revenue, so the business today is better understood as a cost center than a profit engine.

The 74% gross margin shows the underlying service is high-margin per dollar, but with near-zero revenue the entire model is a question mark until volume materializes.

Business quality (Unprofitable): Unprofitable: revenue is negligible while operating costs run at a level that produces a deeply negative operating margin. The business has not yet demonstrated a path to self-funding.

Bull case

  • Strong unit economics embedded: Gross margin sits at 74% (10-Q), meaning each dollar of service revenue keeps roughly 74 cents before overhead. If the company can grow bookings even modestly, that margin structure gives it room to absorb fixed costs and reach break-even faster than a low-margin operator would.

Bear case

  • Costs dwarf any revenue: Operating margin is -535% (10-Q), which means the company spends more than five times its (near-zero) revenue on operations. Until revenue scales meaningfully, every quarter likely deepens the cash burn.
  • No validated demand yet: The company reports essentially no revenue for the period (10-Q). Without a meaningful top line, there is no evidence that customers are paying at a scale that would justify the current cost structure.
Valuation — source: SEC EDGAR (first-party)
Price$10.01
Market Cap$83.07M
P/E Ratio494.2
Price / Book159.76
Price / Sales303.89
Profitability & Growth — source: SEC EDGAR
Return on Equity32.3%
Current Ratio2.51

Related Companies (Business Services; 8 comparable business services companies)

  • 20/20 Biolabs, Inc. Common Stock (AIDX)
  • iSpecimen Inc. (ISPC)
  • VolitionRx Limited (VNRX)
  • Absci Corporation (ABSI)
  • Q/C Technologies, Inc. (QCLS)
  • OneMedNet Corporation (ONMD)
  • Insight Molecular Diagnostics Inc. (IMDX)
  • Biomerica, Inc. (BMRA)
BNBX earnings history · BNBX institutional & insider holders · BNBX KPIs & operating metrics · BNBX financials · BNBX investor presentations & press releases · BNBX SEC filings · BNBX peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-28.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.